Supreme Court Backs Maker of Generic Heart Drug in 'Skinny Label' Case

(MedPage Today) -- Amarin Pharma has not done enough to definitively show that its generic competitor, Hikma Pharmaceuticals, is infringing on Amarin's patents for its anti-hypertriglyceridemia drug icosapent ethyl (Vascepa), the Supreme Court...
Source
MedPage Today
Opens original article in a new tab



